AZD6094 (HMPL-504)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AZD6094 (HMPL-504), covering 2017-10-12 to 2017-10-12. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II Trial to Evaluate the Efficacy of AZD6094 (HMPL-504) in Patients With Papillary Renal Cell Carcinoma (PRCC) [Phase 2]